Advanced search
Publication Cover
Journal of Liposome Research Volume 12, 2002 - Issue 1-2
Submit an article Journal homepage
4,252
Views
12
CrossRef citations to date
0
Altmetric
Research Article

LIGAND-TARGETED LIPOSOMES DIRECTED AGAINST PATHOLOGICAL VASCULATURE

Raymond M. Schiffelers Dept. of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), P.O. Box 80082, TB Utrecht, 3508, The Netherlands
,
Grietje Molema Dept. Pathology and Laboratory Medicine, Groningen University Institute for Drug Exploration (GUIDE), Groningen, The Netherlands
,
Timo L. M. ten Hagen Dept. of Surgical Oncology, Academic Hospital Rotterdam - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
,
Adriënne P. C. A. Janssen Dept. of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), P.O. Box 80082, TB Utrecht, 3508, The Netherlands
,
Astrid J. Schraa Dept. Pathology and Laboratory Medicine, Groningen University Institute for Drug Exploration (GUIDE), Groningen, The Netherlands
,
Robbert J. Kok Dept. of Pharmacokinetics and Drug Delivery, GUIDE, Groningen, The Netherlands
,
Gerben A. Koning Dept. of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), P.O. Box 80082, TB Utrecht, 3508, The Netherlands
&
Gert Storm Dept. of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), P.O. Box 80082, TB Utrecht, 3508, The Netherlands
 show all
Pages 129-135 | Published online: 15 Jul 2002

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Josbert M Metselaar & Gert Storm. (2005) Liposomes in the treatment of inflammatory disorders. Expert Opinion on Drug Delivery 2:3, pages 465-476.
Read now
Martin Bartsch, Alida H. Weeke-Klimp, Dirk K. F. Meijer, Gerrit L. Scherphof & Jan A. A. M. Kamps. (2005) Cell-Specific Targeting of Lipid-Based Carriers for ODN and DNA. Journal of Liposome Research 15:1-2, pages 59-92.
Read now
. (2003) Literature Alerts. Journal of Microencapsulation 20:2, pages 279-287.
Read now

Articles from other publishers (9)

Disha N. Moholkar, Raghuram Kandimalla, Ramesh C. Gupta & Farrukh Aqil. (2023) Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes. Cancer Letters 565, pages 216220.
Crossref
Danielle S.W. Benoit, Clyde T. Overby, Kenneth R. Sims Jr.Marian A. Ackun-Farmmer. 2020. Biomaterials Science. Biomaterials Science 1237 1266 .
Patrick S. Stayton, Bilal Ghosn & John T. Wilson. 2013. Biomaterials Science. Biomaterials Science 1028 1036 .
Döne Demirgöz, Ashish Garg & Efrosini Kokkoli. (2008) PR_b-Targeted PEGylated Liposomes for Prostate Cancer Therapy. Langmuir 24:23, pages 13518-13524.
Crossref
Claudia Ryppa, Hagit Mann-Steinberg, Iduna Fichtner, Holger Weber, Ronit Satchi-Fainaro, Martin L. Biniossek & Felix Kratz. (2008) In Vitro and in Vivo Evaluation of Doxorubicin Conjugates with the Divalent Peptide E-[c(RGDfK) 2 ] that Targets Integrin α v β 3 . Bioconjugate Chemistry 19:7, pages 1414-1422.
Crossref
Gerben A. Koning, Raymond M. Schiffelers, Marca H. M. Wauben, Robbert J. Kok, Enrico Mastrobattista, Grietje Molema, Timo L. M. ten Hagen & Gert Storm. (2006) Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate–containing RGD peptide liposomes inhibits experimental arthritis. Arthritis & Rheumatism 54:4, pages 1198-1208.
Crossref
Christopher J. Sunderland, Matthias Steiert, James E. Talmadge, Austin M. Derfus & Stephen E. Barry. (2006) Targeted nanoparticles for detecting and treating cancer. Drug Development Research 67:1, pages 70-93.
Crossref
Samuel Achilefu, Sharon Bloch, Mary A. Markiewicz, Tuoxiu Zhong, Yunpeng Ye, Richard B. Dorshow, Britton Chance & Kexian Liang. (2005) Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proceedings of the National Academy of Sciences 102:22, pages 7976-7981.
Crossref
C Carrion, M.A de Madariaga & J.C Domingo. (2004) In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34+ leukemic cells. Life Sciences 75:3, pages 313-328.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.